Oral contraceptive and IUD use and endometrial cancer: A population-based case-control study in Shanghai, China

International Journal of Cancer

Volumn 119, Issue 9, 2006, Pages 2142-2147

  Tao, Meng Hua ^a,b   Xu, Wang Hong ^c   Zheng, Wei ^a   Zhang, Zuo Feng ^b   Gao, Yu Tang ^c   Ruan, Zhi Xian ^c   Cheng, Jia Rong ^c   Gao, Jing ^c   Xiang, Yong Bing ^c   Shu, Xiao Ou ^a,d  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SHANGHAI CANCER INSTITUTE   (China)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

Endometrial cancer; Intrauterine device (IUD); Oral contraceptives (OCs)

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CANCER RISK; CHINA; CHINESE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; FEMALE; HIGH RISK POPULATION; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LOGISTIC REGRESSION ANALYSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK REDUCTION; TREATMENT DURATION;

EID: 33748852718     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22081     Document Type: Article

References (27)

1. Weiderpass E, Adami HO, Baron JA, Magnusson C, Lindgren A, Persson I. Use of oral contraceptives and endometrial cancer risk (Sweden). Cancer Causes Control 1999;10:277-84.
2. Vessey MP, Painter R. Endometrial and ovarian cancer and oral contraceptives-findings in a large cohort study. Br J Cancer 1995;71:1340-2.
3. Voigt LF, Deng Q, Weiss NS. Recency, duration, and progestin content of oral contraceptives in relation to the incidence of endometrial cancer (Washington, USA). Cancer Causes Control 1994;5:227-33.
4. Jick SS, Walker AM, Jick H. Oral contraceptives and endometrial cancer. Obstet Gynecol 1993;82:931-5.
5. Stanford JL, Brinton LA, Berman ML, Mortel T, Twiggs LB, Barrett RJ, Wilbanks GD, Hoover RN. Oral contraceptives and endometrial cancer: do other risk factors modify the association? Int J Cancer 1993;54:243-8.
6. Levi F, La Vecchia C, Gulie C, Negri E, Monnier V, Franceschi S, Delaloye JF, De Grandi P. Oral contraceptives and the risk of endometrial cancer. Cancer Causes Control 1991;2:99-103.
7. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. Combination oral contraceptives use and the risk of endometrial cancer. JAMA 1987;257:796-800.
8. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Endometrial cancer and combined oral contraceptives. Int J Epidemiol 1988;17:263-9.
9. La Vecchia C, Decarli A, Fasoli M, Franceschi S, Gentile A, Negri E, Parazzini F, Tognoni G. Oral contraceptives and cancers of the breast and of the female genital tract. Interim results from a case-control study. Br J Cancer 1986;54:311-17.
10. Trapido EJ. A prospective cohort study of oral contraceptives and cancer of the endometrium. Int J Epidemiol 1983;12:297-300.
11. Shu XO, Brinton LA, Zheng W, Gao YT, Jin F, Fraumeni JF. A population-based case-control study of endometrial cancer in Shanghai, China. Int J Cancer 1991;49:38-43.
12. Zha B. The trends of contraceptives of people in Shanghai since early 1980s. China Popul Res Newsl 1996;1:5, 6.
13. Bilian X. Intrauterine devices. Best Pract Res Clin Obstet Gynaecol 2002;16:155-68.
14. Parazzini F, La Vecchia C, Moroni S. Intrauterine device use and risk of endometrial cancer. Br J Cancer 1994;70:672, 673.
15. Castellsague X, Thompson WD, Dubrow R. Intra-uterine contraception and the risk of endometrial cancer. Int J Cancer 1993;54:911-16.
16. Sturgeon SR, Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Lurain JR. Intrauterine device use and endometrial cancer risk. Int J Epidemiol 1997;26:496-500.
17. Hill DA, Weiss NS, Voigt L, Beresford SA. Endometrial cancer in relation to intra-uterine device use. Int J Cancer 1997;70:278-81.
18. Benshushan A, Paltiel O, Rojansky N, Brzezinski A, Laufer N. IUD use and the risk of endometrial cancer. Eur J Obstet Gynecol Reprod Biol 2002;105:166-9.
19. Rosenblatt KA, Thomas DB. Intrauterine devices and endometrial cancer. Contraception 1996;54:329-32.
20. Chen JL, Smith KB, Morrow S, Glasier A, Cheng L. The acceptability of combined oral hormonal contraceptives in Shanghai, People's Republic of China. Contraception 2003;67:281-5.
21. Likis FE. Contraceptive applications of estrogen. J Midwifery Womens Health 2002;47:139-56.
22. Althuis MD, Brogan DR, Coates BJ, Daling JR, Gammon MD, Malone KE, Schoenberg JB, Brinton LA. Hormonal content and potency of oral contraceptives and breast cancer risk among young women. Br J Cancer 2003;88:50-7.
23. Ortiz ME, Croxatto HB. The mode of action of IUDs. Contraception 1987;36:37-53.
24. Guleria K, Agarwal N, Mishra K, Gulati R, Mehendiratta A. Evaluation of endometrial steroid receptors and cell mitotic activity in women using copper intrauterine device: can Cu-T prevent endometrial cancer? J Obstet Gynaecol Res 2004;30:181-7.
25. Hubacher D, Grimes DA. Noncontraceptive health benefits of intrauterine devices: a systematic review. Obstet Gynecol Surv 2002;57:120-8.
26. World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Depot-medroxyprogesterone acetate (DMPA) and risk of endometrial cancer. Int J Cancer 1991;49:186-90.
27. Fowke JH, Shu XO, Dai Q, Jin F, Cai QY, Gao YT, Zheng W. Oral contraceptive use and breast cancer risk: modification by NAD(P)H: quinone oxoreductase (NQO1) genetic polymorphisms. Cancer Epidemiol Biomarkers Prev 2004;13:1308-15.